Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Is Ulcerative Colitis Associated with Survival Among Older Persons with Colorectal Cancer in the US? A Population-Based Case–Control Study

Authors: Aasma Shaukat, Nadim I. Salfiti, Daniel J. Virnig, David H. Howard, Shanthi V. Sitaraman, Jonathan M. Liff, Frank A. Lederle

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Background

While ulcerative colitis (UC) is a risk factor for colorectal cancer, the association of UC with survival after colorectal cancer has not been studied in an older population.

Aims

The objective of our study was to compare the survival of colorectal cancer between persons with and without UC.

Methods

All cases of colorectal cancer (CRC) in persons 67 and older residing in a SEER catchment area and enrolled in the Medicare between 1993 and 1999 were assessed. We identified diagnosis of UC using ICD-9 codes on Medicare outpatient, office, and inpatient claims in the 2 years prior to the date of diagnosis. We used Cox proportional hazards model and Kaplan–Meier curves to compare survival between individuals with UC and CRC (UC–CRC) and sporadic CRC

Results

We identified 47,543 cases of colorectal cancer. Cases with UC–CRC tend to be diagnosed at earlier stages compared to sporadic CRC (42 vs. 37% local (TNM stage 1 and 2) and 11 vs. 17% distant spread (TNM stage 4), respectively; P value = 0.04). Controlling for age, gender, race and stage, diagnosis of UC did not affect the 3-year survival for CRC

Conclusions

Colorectal cancers tend to be diagnosed at earlier stages among persons with UC, but there is no difference in 3-year survival rates for colorectal cancer among individuals with and without UC.
Literature
1.
go back to reference Cotton S, Sharp L, Little J, Cotton S, Sharp L, Little J. The adenoma–carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996;7:293–342.PubMed Cotton S, Sharp L, Little J, Cotton S, Sharp L, Little J. The adenoma–carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996;7:293–342.PubMed
2.
go back to reference Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. [see comment]. Gastroenterology. 1992;103:1602–1610.PubMed Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. [see comment]. Gastroenterology. 1992;103:1602–1610.PubMed
3.
go back to reference Lindberg JO, Stenling RB, Rutegard JN, Lindberg JO, Stenling RB, Rutegard JN. Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis. Endoscopy. 2000;32:359–360.PubMedCrossRef Lindberg JO, Stenling RB, Rutegard JN, Lindberg JO, Stenling RB, Rutegard JN. Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis. Endoscopy. 2000;32:359–360.PubMedCrossRef
4.
go back to reference Odze RD, Odze RD. Adenomas and adenoma-like dalms in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94:1746–1750.PubMedCrossRef Odze RD, Odze RD. Adenomas and adenoma-like dalms in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94:1746–1750.PubMedCrossRef
5.
go back to reference Fogt F, Alsaigh N, Fogt F, Alsaigh N. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: genetic approach to the differential diagnosis (review). Oncol Rep. 1999;6:721–725.PubMed Fogt F, Alsaigh N, Fogt F, Alsaigh N. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: genetic approach to the differential diagnosis (review). Oncol Rep. 1999;6:721–725.PubMed
6.
go back to reference Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (dalm) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366–374.PubMed Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (dalm) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366–374.PubMed
7.
go back to reference Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.PubMedCrossRef Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.PubMedCrossRef
8.
go back to reference Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflammatory Bowel Diseases. 2005;11:314–321.PubMedCrossRef Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflammatory Bowel Diseases. 2005;11:314–321.PubMedCrossRef
9.
go back to reference Shaukat A, Virnig DJ, Salfiti NI, Howard DH, Sitaraman SV, Liff JM (2011) Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Dig Dis Sci. 56:2378–2383. doi:10.1007/s10620-011-1632-z.PubMedCrossRef Shaukat A, Virnig DJ, Salfiti NI, Howard DH, Sitaraman SV, Liff JM (2011) Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Dig Dis Sci. 56:2378–2383. doi:10.​1007/​s10620-011-1632-z.PubMedCrossRef
10.
go back to reference Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. [see comment]. Gut. 1998;42:711–714.PubMedCrossRef Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. [see comment]. Gut. 1998;42:711–714.PubMedCrossRef
11.
go back to reference Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424.PubMed Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424.PubMed
12.
go back to reference Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–342.PubMedCrossRef Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–342.PubMedCrossRef
13.
go back to reference Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflammatory bowel diseases. 2006;12:205–211.PubMedCrossRef Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflammatory bowel diseases. 2006;12:205–211.PubMedCrossRef
14.
go back to reference Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101:1283–1287.PubMedCrossRef Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101:1283–1287.PubMedCrossRef
15.
go back to reference Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the seer-medicare data: CONTENT, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3–IV-18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the seer-medicare data: CONTENT, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3–IV-18.
16.
go back to reference Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Colorectal cancer complicating inflammatory bowel disease: Similarities and differences between crohn’s and ulcerative colitis based on three decades of experience. Ann Surg. 2010;252:330–335.PubMedCrossRef Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Colorectal cancer complicating inflammatory bowel disease: Similarities and differences between crohn’s and ulcerative colitis based on three decades of experience. Ann Surg. 2010;252:330–335.PubMedCrossRef
17.
go back to reference Lutgens MW, Vleggaar FP, Schipper ME, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 2008;57:1246–1251.PubMedCrossRef Lutgens MW, Vleggaar FP, Schipper ME, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 2008;57:1246–1251.PubMedCrossRef
18.
go back to reference Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based danish follow-up study. Am J Gastroenterol. 2007;102:163–167.PubMedCrossRef Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based danish follow-up study. Am J Gastroenterol. 2007;102:163–167.PubMedCrossRef
19.
go back to reference Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011;17:816–822.PubMedCrossRef Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011;17:816–822.PubMedCrossRef
Metadata
Title
Is Ulcerative Colitis Associated with Survival Among Older Persons with Colorectal Cancer in the US? A Population-Based Case–Control Study
Authors
Aasma Shaukat
Nadim I. Salfiti
Daniel J. Virnig
David H. Howard
Shanthi V. Sitaraman
Jonathan M. Liff
Frank A. Lederle
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1966-6

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.